Affirm Holdings, Inc. (NASDAQ:AFRM – Get Free Report) CFO Robert O’hare sold 79,039 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $70.01, for a total value of $5,533,520.39. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Robert O’hare also recently made the following trade(s):
- On Friday, November 22nd, Robert O’hare sold 11,218 shares of Affirm stock. The stock was sold at an average price of $70.00, for a total value of $785,260.00.
- On Monday, November 11th, Robert O’hare sold 100,938 shares of Affirm stock. The stock was sold at an average price of $55.00, for a total value of $5,551,590.00.
Affirm Price Performance
Affirm stock opened at $68.37 on Thursday. The company has a debt-to-equity ratio of 2.50, a quick ratio of 12.60 and a current ratio of 12.60. Affirm Holdings, Inc. has a 52 week low of $22.25 and a 52 week high of $70.20. The stock has a market capitalization of $21.47 billion, a P/E ratio of -48.15 and a beta of 3.47. The stock has a fifty day moving average of $47.84 and a 200-day moving average of $37.25.
Hedge Funds Weigh In On Affirm
A number of institutional investors and hedge funds have recently bought and sold shares of AFRM. Dragoneer Investment Group LLC acquired a new position in Affirm in the 2nd quarter worth about $45,219,000. Artemis Investment Management LLP acquired a new position in Affirm in the 3rd quarter worth about $30,808,000. Holocene Advisors LP acquired a new position in Affirm in the 3rd quarter worth about $27,872,000. Charles Schwab Investment Management Inc. increased its holdings in Affirm by 44.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,203,210 shares of the company’s stock worth $89,935,000 after purchasing an additional 672,883 shares in the last quarter. Finally, Bank of Montreal Can grew its position in shares of Affirm by 269.7% in the 3rd quarter. Bank of Montreal Can now owns 724,336 shares of the company’s stock valued at $29,814,000 after buying an additional 528,400 shares during the last quarter. Institutional investors and hedge funds own 69.29% of the company’s stock.
Analysts Set New Price Targets
AFRM has been the subject of several research analyst reports. Wells Fargo & Company lifted their target price on Affirm from $52.00 to $55.00 and gave the stock an “overweight” rating in a research note on Friday, November 8th. BTIG Research upgraded Affirm from a “neutral” rating to a “buy” rating and set a $68.00 price target for the company in a research note on Tuesday, October 8th. Morgan Stanley upgraded Affirm from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $22.00 to $37.00 in a research note on Wednesday, October 9th. The Goldman Sachs Group boosted their price target on Affirm from $46.00 to $54.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Finally, Susquehanna boosted their price target on Affirm from $52.00 to $57.00 and gave the company a “positive” rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, Affirm has an average rating of “Hold” and a consensus price target of $51.13.
Check Out Our Latest Stock Report on AFRM
About Affirm
Affirm Holdings, Inc operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months.
Further Reading
- Five stocks we like better than Affirm
- ESG Stocks, What Investors Should Know
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Invest in Small Cap StocksĀ
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Affirm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affirm and related companies with MarketBeat.com's FREE daily email newsletter.